Venture Partner at Nucleus Capital
Check size: Up to €1M initially, as published by Nucleus Capital.
Martin Weber invests through Nucleus Capital's published strategy: Write first checks into European and US founders applying programmable biology and deep technology to food, materials and neo-industrial systems.
Show founder-market fit, the problem and product, technical or commercial differentiation, traction, market scale, financing plan and why Nucleus Capital's stated focus is a match.
Founders whose work fits Nucleus Capital's stated focus and who can show a large problem, differentiated insight, credible execution and evidence appropriate to the stage.
Opportunities outside Nucleus Capital's published stage, geography or sector focus are less aligned; no broader exclusion is inferred where the firm does not publish one.